Our Commitment

We are committed to making our website accessible and inclusive. Our journey with website accessibility began on 05/20/2024 and our efforts are ongoing. Our website team implements continuous improvements over time. We regularly test for accessibility and remediate our findings as needed.


We welcome your feedback on the accessibility of Inhibitor Therapeutics, Inc. Please let us know if you encounter accessibility barriers or would like something to be made accessible on Inhibitor Therapeutics, Inc.

You can submit your request here.

Conformance status

The Web Content Accessibility Guidelines (WCAG) defines guidelines for designers and developers to improve accessibility for people with disabilities. Inhibitor Therapeutics, Inc aims to provide full and equal enjoyment of our website for all our users. We have designed our site to our good faith understanding of WCAG 2.2 level AA.


Below is a description of potential delays in providing accessible versions. Please contact us if you observe an issue not listed below or to request an accessible version of the content under Inhibitor Therapeutics, Inc's control.

Known delays for Inhibitor Therapeutics, Inc:

Earnings Webcasts/Media

  • Accessible media for earnings webcasts or other media can be created upon request.

Third-party Content/Websites

  • Websites, Media, Content or Third-party Code that is not under the author's control or linked to another website may not be accessible.

SEC Filings and Press Releases

  • Accessible versions of SEC Filings and Press Releases can be created upon request.

Presentations/Reports (PDFs)

  • Accessible versions of PDF presentations/reports can be created upon request.